GH Research is trading at $19.10, down -5.82%, with no clear company-specific catalyst identified for the November 4 decline.
- Its investor-relations page lists August 6 as the latest release.
- GH Research is scheduled to report Q3 results on November 5; an earnings preview does not establish the reason for the move.
- The supplied sector context shows biotech higher, and volume information was unavailable.